Bronchial asthma is considered an umbrella diagnosis for various diseases with certain pathophysiological mechanisms (endotypes) and variable clinical manifestations (phenotypes). The phenotype of exercise-induced asthma is one of the most common variants of the disease in children and adolescents. The treatment tactic of acute asthma attack is unified and depends of the severity in contrast to preventive therapy the vector of which provides an individualized approach. However, the issues concerning the duration, frequency of administration and amount of drugs prescription not finally resolved. The purpose of the study was to evaluate the blood immunological parameters in patients with exercise-induced asthma phenotype to predict the severity of disease exacerbation and optimize the reliever therapy. Material and methods. We examined 43 children suffering from exercise-induced asthma. Two clinical groups were formed according to the severity of the exacerbation. The first group included 22 patients with moderate exacerbation of asthma, and the second group had 21 children with severe symptoms of the disease, which was interpreted as a severe asthma attack. There were not any significant differences by sex, place of residence, age and diseases duration among comparison groups. The obtained results showed a significant increase in the level of B-lymphocytes in patients of first clinical group (26.64 %) compared with children with severe exacerbation (20.40 %), increase content of T-lymphocytes (due to T-helper cells) in schoolchildren of the second clinical group (42.32 %) compared with patients with moderate asthma attack (33.32 %). The attributive risk of more severe disease exacerbation with B-lymphocytes ≤20 % and T- helper cells ≥20 % was 36.6 %, the relative risk was 1.9 with odds ratio 5.0. A significantly higher level of pharmazan-positive neutrophils in spontaneous and stimulated modifications of the nitro blue tetrazolium test was recorded in patients with moderate exacerbation (35.18 % and 45.09 %) compared with children of the second clinical group (19.33 % and 27.81 %). The content of neutrophils in the spontaneous nitro blue tetrazolium test ≤15 % allowed evaluating severe compared with moderate asthma attack with specificity of 95.5 %, positive predictive value of 90.9 %, and positive likelihood ratio 10.5. Conclusion. The use of certain immunological parameters allows working out an individual plan for asthma attacks and may reduce the frequency of severe exacerbations in children suffering from exercise-induced bronchial asthma
The results of the clinical efficacy of basic treatment of school-age children with bronchial asthma have been presented. It has been found that patients with an early-onset phenotype of asthma had a higher risk of not gaining control over the symptoms of the disease (odds ratio – 6,0) and exacerbations (odds ratio – 2,7) compared with children whose disease set in after six years.
Вищий державний навчальний заклад України «Буковинський державний медичний університет», м. Чернівці Резюме. У роботі проаналізована ефективність симптоматичного лікування нападного періоду неатопічного фенотипу бронхіальної астми в дітей залежно від типу ацетиляторних процесів. Виявлено, що вихідні показники тяжкості бронхообструкції суттєво не залежать від механізму ацетил яторних процесів. Не зважа-ючи на адекватний обсяг полегшувальної терапії, більш виражений синдром бронхообструкції в динаміці відзначався серед пацієнтів із швидким типом ацетилювання. Ключові слова: бронхіальна астма, діти, лікування, фенотип, ацетиляторні механізми.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.